Williams Eugene's Form 4 filing
ProMIS Neurosciences Inc. (PMN) · filed Dec 19, 2022
- Accession no.
- 0001927626-22-000004
- Filed
- Dec 19, 2022
- Trade date
- Dec 16, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $9.29K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Williams EugeneCIK 0001927626 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2022 | Common Shares | PPurchaseAcquired | +1,000 | $4.65 | +$4,650 | 158,930 | Direct | |
| Dec 16, 2022 | Common Shares | PPurchaseAcquired | +1,000 | $4.64 | +$4,640 | 159,930 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.